Nvidia, Amgen back AI-driven drug firm Generate:Biomedicines’ $273 million fundraise
(Reuters) – Drug developer Generate:Biomedicines, which uses artificial intelligence (AI) to find new treatments, said on Thursday it has raised $273 million from investors including Nvidia’s venture capital arm and Amgen. The…
